Murat AYAN, Ufuk TAŞ, Erkan SÖĞÜT, Semih ARICI, SERKAN KARAMAN, MEHMET ESEN, Fazlı DEMİRTÜRK

Primer dismenore ağrılı hastalarda diklofenak sodyum ve parasetamol tedavi etkinliklerinin vizüel analog skala kullanılarak karşılaştırılması

Amaç: Bu çalışmada, acil servise primer dismenore nedeni ile başvuran hastaların ağrılarının giderilmesinde diklofenak sodyum ve parasetamol tedavi etkinliklerinin Vizüel Analog Skala (VAS) kullanılarak karşılaştırılması amaçlandı. Gereç ve Yöntem: Çalışmaya primer dismenore (Grup 1, n=40) tanısı konmuş olan, parasetamol (1 gr intravenöz) tedavisi verilen ve (Grup 2, n=40) primer dismenore, diklofenak sodyum (75 mg intramüsküler) tedavisi alan kişiler alındı. Her iki grupta da 19-30 yaş arasındaki hastalar seçildi. Tüm gruplarda hastaların ağrı şiddeti VAS kullanılarak 0 (ağrı olmaması) ile 10 (dayanılmaz ağrı) arasında derecelendirildi. Grupların VAS ları karşılaştırıldı. Bulgular: İki grup arasında yaş, OAB ve Nb değerleri açısından istatistiksel olarak fark yoktu. I. gruptaki bireylerin başvuru sıra- sındaki VAS değerleri II. gruptakilerden yüksek iken, onuncu ve otuzuncu dakikalardaki VAS değerleri II. gruptaki hastalardan daha düşüktü (p=0.00). I. ve II. grubun her birinin kendi içindeki başlangıçtaki, 10. ve 30. dakikalardaki VAS değerleri birbirle- rinden anlamlı derecede farklıydı. 10. ve 30. dakikadaki VAS değerleri başlangıçtaki değerlere göre, 30. dakikadaki VAS değerleri 10. dakikaya göre anlamlı derecede düşüktü (p=0.00). Sonuç: Çalışma sonucunda parasetamolün primer dismenore ağrısı tedavisinde diklofenak sodyum dan daha hızlı etki gös- terdiği ve daha etkili olduğu söylenebilir.

Comparing efficiencies of diclofenac sodium and paracetamol in patients with primary dysmenorrhea pain by using visual analog scale

Objectives: The aim of this study was to compare the efficiency of diclofenac sodium to paracetamol using a visual analog scale in the patients presenting to the emergency room with primary dysmenorrhea. Methods: Group I (n=40) patients were diagnosed with primary dysmenorrhea and treated with paracetamol (1 gr intravenous) and Group II (n=40) patients were diagnosed with primary dysmenorrhea and treated with diclofenac sodium (75 mg intramuscular). In both groups, patients were 19-30 years old. In all groups, the intensity of the pain was ranked from 0 (no pain) to 10 (intolerable) using VAS. The VAS scores were compared between treatment groups. Results: Between two groups, there was no statistically significant difference in age, mean arterial pressure and pulse values. The initial VAS values of the first group were higher than that of 2nd group. Following treatment, in the 10th and 30th minutes, the VAS values were lower in Group I than Group II (p=0.00). The VAS values of each group were significantly different from each other on the 10th and 30th minutes. VAS values at the 10th and 30th minutes were lower compared to the initial values and the values in the 30th minute were lower relative to the 10th minute (p=0.00) in both treatment groups. Conclusion: We can suggest that paracetamol is more efficient than diclofenac sodium in the treatment of primary dysmenorrhea.

PDF

___

1.Callejo J, Díaz J, Ruiz A, García RM. Effect of a low-dose oral contraceptive containing 20 microg ethinylestradiol and 150 microg desogestrel on dysmenorrhea. Contraception 2003;68(3):183-8.
2.Ma YX, Ma LX, Liu XL, Ma YX, Lv K, Wang D, et al. A compara- tive study on the immediate effects of electroacupuncture at Sanyinjiao (SP6), Xuanzhong (GB39) and a non-meridian point, on menstrual pain and uterine arterial blood flow, in primary dysmenorrhea patients. Pain Med 2010;11(10):1564- 75.
3.Coco AS. Primary dysmenorrhea. Am Fam Physician 1999;60(2):489-96.
4.Nikles CJ, Yelland M, Del Mar C, Wilkinson D. The role of paracetamol in chronic pain: an evidence-based approach. Am J Ther 2005;12(1):80-91.
5.Sachs CJ. Oral analgesics for acute nonspecific pain. Am Fam Physician 2005;71(5):913-8.
6.Bektas F, Eken C, Karadeniz O, Goksu E, Cubuk M, Cete Y. In travenous paracetamol or morphine for the treatment of re nal colic: a randomized, placebo-controlled trial. Ann Emerg Med 2009;54(4):568-74.
7.Hyllested M, Jones S, Pedersen JL, Kehlet H. Comparative ef fect of paracetamol, NSAIDs or their combination in postop erative pain management: a qualitative review. Br J Anaesth 2002;88(2):199-214.
8.Jones KR, Vojir CP, Hutt E, Fink R. Determining mild, moderate, and severe pain equivalency across pain-intensity tools in nursing home residents. J Rehabil Res Dev 2007;44(2):305-14.
9.Paul SM, Zelman DC, Smith M, Miaskowski C. Categorizing the severity of cancer pain: further exploration of the estab lishment of cutpoints. Pain 2005;113(1-2):37-44.
10.Erdine S. Ağrı mekanizmaları ve ağrıya genel yaklasım. In: Er dine S, editör. Ağrı. 3. baskı. İstanbul: Nobel Tıp Kitabevleri; 2007. p. 37-49.
11.Heavner J. Ağrı mekanizması: Klinik pratik için bilimsel temeller. In: Erdine S, editör. Rejyonel anestezi. İstanbul: No bel Tıp Kitabevleri; 2005. s. 13-23.
12.Unsal A, Ayranci U, Tozun M, Arslan G, Calik E. Prevalence of dysmenorrhea and its effect on quality of life among a group of female university students. Ups J Med Sci 2010;115(2):138- 45.
13.Larroy C. Comparing visual-analog and numeric scales for as sessing menstrual pain. Behav Med 2002;27(4):179-81.
14.Downie WW, Leatham PA, Rhind VM, Wright V, Branco JA, Anderson JA. Studies with pain rating scales. Ann Rheum Dis 1978;37(4):378-81.
15.Liu CZ, Xie JP, Wang LP, Zheng YY, Ma ZB, Yang H, et al. Im- mediate analgesia effect of single point acupuncture in pri- mary dysmenorrhea: a randomized controlled trial. Pain Med 2011;12(2):300-7.
16.Berek & Novak Jinekoloji (Andrea J. Rapkin, Cndace N. Howe). Çeviri editörü; Erk A, Demirtürk F. Pelvik ağrı ve dismenore (Burçin Demirel). Nobel tıp kitabevi. 2011. Sayfa 505-40.
17.Harel Z. Dysmenorrhea in adolescents and young adults: etiology and management. J Pediatr Adolesc Gynecol 2006;19(6):363-71.
18.Tolman EL, Fuller BL, Rosenthale ME. Potent and selective ef fects of suprofen on uterine prostaglandin synthesis. Prosta glandins Leukot Med 1985;18(3):367-77.
19.Aronoff DM, Oates JA, Boutaud O. New insights into the mechanism of action of acetaminophen: Its clinical pharma cologic characteristics reflect its inhibition of the two prosta glandin H2 synthases. Clin Pharmacol Ther 2006;79(1):9-19.
20.Graham GG, Scott KF. Mechanism of action of paracetamol. Am J Ther 2005;12(1):46-55.
21.Harel Z. A contemporary approach to dysmenorrhea in ado lescents. Paediatr Drugs 2002;4(12):797-805.
22.Hyllested M, Jones S, Pedersen JL, Kehlet H. Comparative ef fect of paracetamol, NSAIDs or their combination in postop erative pain management: a qualitative review. Br J Anaesth 2002;88(2):199-214.